Rapid quality control test SC-2030-25

for propoxypheneurineimmunochromatographic

SCREEN 1 PROPOSSIFENE One Step Drug Test Card REF: SC-2030-25 The Rapid Screen 1 Propoxyphene PPX test (Urine) is a rapid immunochromatographic test for the detection of Propoxyphene in human urine at a concentration of 300 ng/mL. It is a diagnostic test for use by healthcare professionals, including those in point of care. This test can detect other related compounds, please refer to the Analytical Specificity table in this package insert. Propoxyphene (PPX) is a narcotic analgesic compound with a structure similar to methadone. As an analgesic, propoxyphene can be as potent as 50-75% of oral codeine. Darvocet ™, one of the most common trade names for the drug, contains 50-100 mg of propoxyphene napsylate and 325-650 mg of acetaminophen. Peak plasma concentrations of propoxyphene are reached 1-2 hours after the dose. In the event of an overdose, the concentrations of propoxyphene in the blood can reach significantly higher levels. In humans, propoxyphene is metabolised by N-demethylation to norpropoxyphene. Norpropoxyphene has a longer half-life (from 30 to 36 hours) than the parent propoxyphene (from 6 to 12 hours). The accumulation of norpropoxyphene shown with repeated doses can be largely responsible for the resulting toxicity. The PPX rapid test (Urine) is a rapid urine control test that can be performed without the use of instruments. The test uses a monoclonal antibody to selectively detect high levels of Propoxyphene in urine. The PPX rapid test (Urine) gives a positive result when the Propoxyphene in the urine exceeds 300 ng/mL.